# Novartis pens $7.8B deal for Abogen's in vivo autoimmune T-cell engager

> **Newsylist Open Intelligence Dossier** · First detected: 2026-10-02 18:29 UTC · Category: Business · Sources: 5 · Current Velocity: 2.8

## Key People, Organizations & Locations
Novartis, T-cell, Abogen

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Bloomberg.com | Novartis Inks Chinese mRNA-Therapy Deal for Up to $7.8 Billion | 2026-10-02 08:24 | [Source Link](https://news.google.com/rss/articles/CBMisgFBVV95cUxORlo2VnlsZVRFdVp0d3hNa2d6QnZkR2RIcWI1OGpCa2VWaWFycXZQM0V6eGZkSkNMeThMbU05UW5HdldvdUdacHpzNXNQMkpkM19EN09HRXg1ZWljaXdTa1ZmWXVSUVVmb2ZCNEw5a3VKa0FtUFdUR2dsZDhtTjNMZjBLQ1hfYkF2V0RUb3ExbHhwSWMwSE5MNl9iZ3JQb0JnNENPZ3R3SnVMQTVMd1llTTR3?oc=5) |
| cnbc.com | Big Pharma’s China deal spree grows with latest tie-up worth up to $7.8 billion | 2026-10-02 08:24 | [Source Link](https://news.google.com/rss/articles/CBMie0FVX3lxTE9QYm51cUFUM2dqNUhwM203ekVWOWVsblB5Y3AtZHYyWGx2bTFjMWpNU3Y0U0UxN1NHSk5GMllabWxLdjBiRDBJLThtZEM4Z3ZGWkRDSlhOQ1BjZzVNMTVicFRLQ3VJVGhlZHJTOUh6d2p5YXVObHVkdGJZQdIBgAFBVV95cUxNUWVtRDEyZUNXM1pEdm9oU1E2TzI4TXV2bktEaHo5ZnhVMHJiNXBKUFJYVC02b0hFWWxHQnBscDhYay1TSTE0RC05WHUyRDFoS2xPaXJqSG5TLWFsUUNKT0NGS0tLa3VWMEFzQkFTNm1taGdVbk5qZUhuQ3hOZU9UVw?oc=5) |
| Axios | Novartis signs $7.8 billion drug deal with Chinese startup | 2026-10-02 08:24 | [Source Link](https://news.google.com/rss/articles/CBMiYkFVX3lxTE1pZ3JZOFhVLTEyemswLXk5UGFUMjlNdWhhT3R5LTlIQ2VmRDBxZmlnVDRrSXZ1WDlHMzE4MDFYY29XSmRqUmltRnhvX2NoT0ZsV2Q2ZjlERkVtQ0xfMzZVQzln?oc=5) |
| Reuters | Novartis strikes up to $7.8 billion mRNA deal with China's Abogen | 2026-10-02 08:24 | [Source Link](https://news.google.com/rss/articles/CBMitgFBVV95cUxNZWh5dEJ1LTdGU0pVQkdPODNVU2YybE5ielZvYkMyLTFnZWtxSU8xR21hXzVCVVhNb3NlQ3VIVnRqUFNZdjZNVjgtOHQybGNDTmlsVllPSWxoQ3B2WVN6Y3lxVHJ1ZDFKSi1jVktDbm84Zk9vSGtVVGNXUmNIektOYkN4azBxanNsbThzNTRCUGdQQ2lpbG9Zb19hSEpjbWdrVXpoSDV1b2NUNXZ6ZTA1MzhiTTN0QQ?oc=5) |
| Fierce Biotech | Novartis pens $7.8B deal for Abogen's in vivo autoimmune T-cell engager | 2026-10-02 08:24 | [Source Link](https://news.google.com/rss/articles/CBMimgFBVV95cUxOdzFFVmNSUENDSVN2WnRTZjhFc3Q3M0ZQZjJHTG42Zk9vRFZkVl9NQmptQXhMSVVKSmE2TTRweXlGWFJGVl9Ca0U4YzVlQncxSjRFejlVdlBZLUtOMzdPRWV4ZFRaaXB3R3RvbnV2X3pPd3NUUUV5cHpqQXJ6UUFuangyWXJMdGtYYU5qdkxCNFFHXzVLcW1ndjZB?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-10-02/novartis-pens-7-8b-deal-for-abogen-s-in-vivo-autoimmune-t-cell-engager*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*